Download HCA protocol for the administration of Hydroxocobalamin to adults

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Pharmacogenomics wikipedia , lookup

National Institute for Health and Care Excellence wikipedia , lookup

Adherence (medicine) wikipedia , lookup

Bilastine wikipedia , lookup

Electronic prescribing wikipedia , lookup

Transcript
DRAFT
Protocol for the Administration of Hydroxocobalamin to adults
by Health Care Assistants (HCA)
Purpose of Protocol
To enable suitably trained Health Care Assistants working for Croydon PCT who
have undertaken relevant training (as outlined below), to administer
hydroxocobalamin as a duty delegated by the General Practitioner (GP employer) or
registered nurse (PCT employee).
Characteristics of staff
Staff group (s)
Health Care Assistants
Additional Requirements
Completion of relevant training (as
outlined below)
Knowledge of Croydon PCT policy on
management Anaphylaxis in the
Community.
Training and competence in the correct
procedure of administering medication
via intra-muscular injection.
Continuing Training Requirement
Annual updates in Basic Life Support and
2 yearly updates in the treatment of
Anaphylaxis.
Demonstration of competence in relation
to this medication within the PDP and
appraisal process.
Clinical Condition
Clinical Condition to be treated
Pernicious or other macrocytic anaemias
Criteria for inclusion
Any adult (i.e. any person aged 18 years
or over) who has received initial
treatment following diagnosis and now
requires maintenance doses.
Criteria for exclusion
Patients with an unconfirmed diagnosis
of pernicious or other macrocytic
anaemia.
Recently diagnosed patients who are
receiving the initial two weeks of
treatment.
Any person less than 18 years of age.
D:\565326550.doc
Page 1 of 6
DRAFT
Adverse reactions
Health Care Assistants must ensure the availability of an Anaphylactic shock of
Adrenaline 1:1000.
If a general adverse reaction does occur:
 Record in patients notes
 Inform patients General Practitioner as soon as possible
 Local reactions should be seen by either the general practitioner or practice
nurse or qualified RN within the district nursing team.
If anaphylactic reaction occurs
 Give treatment in accordance with the PCT policy on the Management of
Anaphylaxis in the community.
 Record in patients notes
 Inform patient General Practitioner as soon as possible
Relevant training
1) The Health Care Assistants will attend a training session covering the following
aspects of the administration of hydroxocobalamin
 Appropriate anatomy and physiology
 Correct procedure for the administration of hydroxocobalamin by
intramuscular injection
 Drug store requirements
 Cautions and side effects related to the administration of hydroxocobalamin
 Documentation
 Legal aspects of drug administration
2) The Health Care Assistant will have successfully completed and passed the
Injection Training Course.
This includes an assessment of competence at
performing CPR and underpinning knowledge of consent issues.
3) The HCA will undergo a period of supervised practice and to be directly observed
administering 5x intramuscular injections of hydroxocobalamin either by the general
practitioner or the practice nurse (GP employee) providing this duty has been
delegated in writing by the general practitioner or by a registered nurse (if employed
by Croydon PCT).
Assessment of competence
Assessment of competence will be undertaken following the period of supervised
practice as outlined above. In the GP Practice, this will be undertaken by the general
practitioner (or by the practice nurse providing that this duty has been delegated in
writing) in order to comply with the specific requirements of the company providing
medical indemnity. If employed by the Croydon PCT, assessment of competence will
be undertaken by an occupationally competent registered nurse.
D:\565326550.doc
Page 2 of 6
DRAFT
Competence will be assessed by direct observation of the HCA’s ability to:
 Prepare the patient for the procedure
 Safe administration of the medication (including choice of site and needle
technique)
 Correct disposal of clinical waste
 Correct documentation
The Health Care Assistant will also be assessed (via oral questioning) on issues
relating to the therapeutics of hydroxocobalamin.
Clinical Aspects
The following will be required:
1. Patient specific directions – written by the General Practitioner
2. Patient identification - required prior to the administration of medication
(confirmed by the patient declaring his or her name, date of birth and home
address).
3. Consent – informed consent must be obtained from the patient.
4. Record keeping – The following should be recorded in the patients notes,
either according to the GP practice system, or within the district nursing
documentation drug administration records
 Name of drug, dose route and site of administration
 Date administered
 Batch No and expiry date
 Signature of person administering
Significant Events
Any significant event which occurs during or as the result of administration of
medication must be reported to the Practice Manager/General Practitioner (GP
employee) or Registered Nurse/Manager (PCT employee), and the incident reported
via the PCT significant event reporting framework.
Audit: The HCA will be expected to participate in audit in relation to patient
outcomes and the development of this role.
The HCA must be familiar with the following documents:







Croydon PCT Medicines Policy (2004)
Croydon PCT Consent Policy (2005)
Croydon PCT Records Management Policy (2005)
Croydon PCT Adverse Incident/Reporting & Managing Policy (2006)
Croydon PCT Clinical Guidelines
NMC Guidelines for the Administration of Medication 2005
NMC Guidelines for Records & Record Keeping 2005
D:\565326550.doc
Page 3 of 6
DRAFT
This protocol has been adapted by Francina Hyatt, Clinical Nurse Trainer/Advisor
Acknowledgement is given to the following people from Salford PCT
Mrs Barbara Jackson
Workforce Modernisation Co-ordinator
Ms Sue Harris
Non-medical Prescribing Lead
Review:
It is the responsibility of the lead of the staff group (s) to whom this protocol applied
to ensure the review process takes place.
This protocol becomes valid on 1st July 2006 and becomes due for review on 1 st July
2008.
D:\565326550.doc
Page 4 of 6
DRAFT
Protocol for Hydroxocobalamin
Agreement for Croydon PCT Health Care Assistants
This protocol is to be read, agreed and signed by all Health Care
Professionals it applies to:
Approved base:
__________________________________
Staff Name:
__________________________________
Designation:
__________________________________
Signature:
__________________________________
Date:
__________________________________
Signature of Team __________________________________
Leader:
Date:
__________________________________
The Health Care Professionals should retain a copy of the document after
signing and the original retained in their personal file.
Expires 1st July 2008
D:\565326550.doc
Page 5 of 6
DRAFT
Protocol for Hydroxocobalamin
Agreement for Croydon PCT Health Care Assistants
This protocol is to be read, agreed and signed by all Health Care
Professionals it applies to:
Practice:
__________________________________
Staff Name:
__________________________________
Designation:
__________________________________
Signature:
__________________________________
Date:
__________________________________
Approved by
Lead GP:
__________________________________
Date:
__________________________________
The Health Care Professionals should retain a copy of the document after
signing and the original retained in their personal file.
Expires 1st July 2008
D:\565326550.doc
Page 6 of 6